Metzger Michael A
SEC insider (Form 3/4/5 filer). CIK 0001507220. Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX) and 1 other issuer. 18 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in NEW YORK, NY.
Companies Metzger Michael A has filed insider reports for
- Syndax Pharmaceuticals Inc (SNDX): Director, Officer, Chief Executive Officer
- Pyxis Oncology, Inc. (PYXS): Director
Metzger Michael A
CIK: 0001507220
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jul 8, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect32.4K shares at avg. $24.24$785K - Jul 8, 2026SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect32.4K shares at avg. $6.38$207K - Jun 1, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect6.8K shares at avg. $18.99$130K - Mar 24, 2026PYXS
Pyxis Oncology, Inc.
AwardDirectStock Option (Right to Buy)
45.9K shares- - Feb 9, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect17.2K shares at avg. $21.03$361K - Feb 6, 2026SNDX
Syndax Pharmaceuticals Inc
SaleDirect7.4K shares at avg. $20.62$153K - Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect144.6K shares- - Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect73K shares- - Sep 8, 2025SNDX
Syndax Pharmaceuticals Inc
SaleDirect157.3K shares at avg. $16.41$2.6M - Sep 8, 2025SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect157.3K shares at avg. $10.90$1.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 |  SNDX Syndax Pharmaceuticals Inc | Sale | 32,375 | $24.24 | $784,776 | Direct |
| Jul 8, 2026 | SNDX Syndax Pharmaceuticals Inc | Exercise | 32,375 | $6.38 | $206,553 | Direct |
| Jun 1, 2026 | SNDX Syndax Pharmaceuticals Inc | Sale | 6,847 | $18.99 | $130,025 | Direct |
| Mar 24, 2026 |  PYXS Pyxis Oncology, Inc. | Award Stock Option (Right to Buy) | 45,867 | - | - | Direct |
| Feb 9, 2026 | SNDX Syndax Pharmaceuticals Inc | Sale | 17,159 | $21.03 | $360,819 | Direct |
| Feb 6, 2026 | SNDX Syndax Pharmaceuticals Inc | Sale | 7,412 | $20.62 | $152,835 | Direct |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Award | 144,600 | - | $0 | Direct |
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Award | 73,000 | - | $0 | Direct |
| Sep 8, 2025 | SNDX Syndax Pharmaceuticals Inc | Sale | 157,307 | $16.41 | $2,582,021 | Direct |
| Sep 8, 2025 | SNDX Syndax Pharmaceuticals Inc | Exercise | 157,307 | $10.90 | $1,714,646 | Direct |
1-10 of 18 transactions